Emerging antibody products and Nicotiana manufacturing.

@article{Whaley2011EmergingAP,
  title={Emerging antibody products and Nicotiana manufacturing.},
  author={Kevin J. Whaley and Andrew Hiatt and Larry Zeitlin},
  journal={Human vaccines},
  year={2011},
  volume={7 3},
  pages={
          349-56
        }
}
Antibody based products are not widely available to address multiple global health challenges due to high costs, limited manufacturing capacity, and long manufacturing lead times. Nicotiana-based manufacturing of antibody products may now begin to address these challenges as a result of revolutionary advances in transient expression and altered glycosylation pathways. This review provides examples of emerging antibody-based products (mucosal and systemic) that could be competitive and… CONTINUE READING

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS

Role of plant expression systems in antibody production for passive immunization.

  • The International journal of developmental biology
  • 2013
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 57 REFERENCES

HIV - 1 neutralization profile and plant - based recombinant expression of Actinohivin and Env glycanspecific lectin temoid of T - cell mitogenic activity

N Matoba, AS Husk, +3 authors DC Montefiori
  • PLoS One
  • 2010

Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2010